z-logo
open-access-imgOpen Access
Posaconazol (Noxafil®) suspensión y comprimidos no deben utilizarse indistintamente sin realizar un ajuste de dosis
Author(s) -
Alejandro Gabriel Catanzariti
Publication year - 2016
Publication title -
evidencia actualizacion en la práctica ambulatoria
Language(s) - Spanish
Resource type - Journals
eISSN - 1851-9776
pISSN - 1667-5703
DOI - 10.51987/evidencia.v19i3.6443
Subject(s) - posaconazole , antifungal , broad spectrum , pharmacology , medicine , chemistry , itraconazole , combinatorial chemistry , dermatology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom